Michael G. Zamagias is the majority owner, and Chairman of the Board, for Pittsburgh-based TeleTracking Technologies, Inc. TeleTracking, a pioneer in operationalizing the care continuum for nearly three decades, believes it is unacceptable that patients are not able to access they care they need, when they need it, due to operating inefficiencies an unnecessary cost barriers. And, with hundreds of billions lost globally through operational waste in U.S. healthcare administration, this gap is creating unavoidable urgency from the boardroom to the front lines of care. That’s why more than a decade ago, TeleTracking recognized the significant benefits of a centralized approach to managing patient flow, led the development of the command center concept, and has implemented more than one hundred operational command centers across the United States and United Kingdom.
Expanding, growing and changing, now with a portfolio of end-to-end patient flow software solutions, and proven best practices, the name TeleTracking describes the journey of the past, present and future. As hospital enterprises spend hundreds of millions to install systems that move patient records, TeleTracking is positioned to add significant value to that spend by offering an interdisciplinary, real-time system that moves people and resources more efficiently and safely than ever before. TeleTracking’s suite of solutions address virtually every point along the care continuum, creating an enterprise-wide platform that automates a hospital’s functional operations and powers live information to the entire enterprise via easy-to-read, graphics-rich digital dashboards that provide a live motion picture of the health system.
TeleTracking has grown significantly since 1991—employing nearly 500 employees with offices in Pittsburgh, PA; Nashville, TN; Raleigh, NC; St. Paul, MN; and London, UK. Named one of Becker’s “Great Places to Work” in 2017 and 2018 and a Pittsburgh Business Times “Corporate Citizenship Award” winner, TeleTracking has also delivered extraordinary outcomes for nearly three decades that have been the subject of study by the RAND Corporation, in addition to being a perennial KLAS category Leader.